If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
11.35    0.15 (1.38%)
Bid:
10.75
Ask:
11.35
Spread: 0.60 (5.581%)
Market Cap: £31.58m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

PORTFOLIO UPDATE

26 May 2017 07:26

RNS Number : 3271G
VPC Specialty Lending Invest. PLC
26 May 2017
 

26 May 2017

 

VPC Specialty Lending Investments PLC

(the "Company")

PORTFOLIO UPDATE

In line with the previously stated strategy of reallocating capital from market place lending to balance sheet lending, the Company is pleased to announce that it has sold the majority of its Funding Circle US and Upstart marketplace loans. The loans sold represented 3.65% and 1.48%, respectively, of the Company's NAV as at 31 March 2017. The impact of the two portfolio sales on the Company's NAV, which the Company estimates to be approximately -0.17%, will be reflected in the April NAV announcement. The Company will retain the non-performing Funding Circle US and Upstart loans, which represented 0.68% and 0.21% respectively of the Company's NAV as at 31 March 2017, and the Company has already been provisioned against these loans in line with the Company's reserving policy. The Company retired the leverage associated with the Upstart loans as part of the transaction, thereby reducing the Company gearing to 0.49x from 0.53x, on a pro forma basis at 31 March 2017.

These tactical sales help accelerate the Company's strategy of reallocating capital away from market place lending investments into balance sheet investments, which consistently have generated higher returns with less volatility. Taking into account the loan sales, the Company's balance sheet investments accounted for 63% of the NAV as at 31 March 2017, as compared to 17% for the marketplace loans. The Company expects to re-invest substantially all of the sale proceeds into balance sheet investments, as well as other strategic uses. The Company will continue to seek tactical opportunities to further reduce its exposure to market place loans where it is accretive to shareholder value.

The information contained in this announcement is inside information. 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner, Investment Manager)

Cormac Leech (Principal)

 

via MHP (below)

Jefferies International Limited

Tel: +44 20 7029 8000

Gary Gould

Andrew MorrisAndrew Davison

Stifel Nicolas Europe Limited

Tel: +44 20 7710 7600

Neil Winward

Mark Bloomfield

Gaudi Le Roux

MHP (PR Adviser)

Tel: +44 20 3128 8100

Mark Lunn

Tim Rowntree

Kelsey Traynor

Email: vpc@mhpc.com

 

ABOUT VPC Specialty Lending Investments PLC:

VPC Specialty Lending Investments PLC invests in opportunities within the specialty lending market primarily through online lending platforms. The Company intends to generate an attractive total return for shareholders consisting of distributable income and capital growth via investments in a diverse portfolio of various platforms, asset classes, geographies (primarily U.S., U.K., Australia and Europe) and credit bands.

 

Since 2010, the Company's investment manager, VPC, has been actively involved in the specialty lending marketplace and has made more than $5.2 billion of investments and commitments across a number of financial technology platforms, multiple geographies (U.S., U.K., Australia and Europe), products (consumer and business) and structures (whole loans and senior credit facilities).

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialitylending.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUEAKSKAAAXEEF
Date   Source Headline
10th Feb 20175:13 pmRNSDirector/PDMR Shareholding
7th Feb 20175:20 pmRNSTransaction in Own Shares
7th Feb 20173:15 pmRNSMonthly Report
7th Feb 20173:15 pmRNSQuarterly Letter
7th Feb 20173:00 pmRNSNet Asset Value(s)
6th Feb 20175:58 pmRNSTransaction in Own Shares
3rd Feb 20175:42 pmRNSTransaction in Own Shares
2nd Feb 20175:39 pmRNSTransaction in Own Shares
2nd Feb 20172:32 pmRNSHolding(s) in Company
1st Feb 20175:39 pmRNSTransaction in Own Shares
1st Feb 20174:51 pmRNSTotal Voting Rights
31st Jan 20176:07 pmRNSTransaction in Own Shares
27th Jan 20174:04 pmRNSHolding(s) in Company
26th Jan 20176:08 pmRNSTransaction in Own Shares
25th Jan 20176:02 pmRNSTransaction in Own Shares
24th Jan 20175:30 pmRNSTransaction in Own Shares
23rd Jan 20175:38 pmRNSTransaction in Own Shares
19th Jan 20175:40 pmRNSTransaction in Own Shares
13th Jan 20175:38 pmRNSTransaction in Own Shares
10th Jan 20177:00 amRNSDirector/PDMR Shareholding
9th Jan 20175:30 pmRNSTransaction in Own Shares
6th Jan 20173:15 pmRNSMonthly Report
6th Jan 20173:00 pmRNSMonthly Net Asset Value Per Share
3rd Jan 20174:58 pmRNSTotal Voting Rights
30th Dec 20161:08 pmRNSTransaction in Own Shares
22nd Dec 20165:00 pmRNSShare Buy-Back Programme and Engagement
22nd Dec 20167:00 amRNSPortfolio Update
30th Nov 20167:00 amRNSDirector/PDMR Shareholding
29th Nov 201610:15 amRNSMonthly Report and Investor Presentation
29th Nov 201610:00 amRNSNet Asset Value(s)
17th Nov 20167:00 amRNSDividend Declaration
1st Nov 20167:00 amRNSDirector/PDMR Shareholding
31st Oct 20162:35 pmRNSQuarterly Letter
31st Oct 20162:30 pmRNSMonthly Update
31st Oct 20162:20 pmRNSNet Asset Value(s)
4th Oct 20167:00 amRNSDirector/PDMR Shareholding
3rd Oct 20163:15 pmRNSMonthly Update
3rd Oct 20163:09 pmRNSNet Asset Value(s)
3rd Oct 20163:00 pmRNSMonthly Update
22nd Sep 20167:00 amRNSHalf-year Report
20th Sep 20167:00 amRNSDirector/PDMR Shareholding
2nd Sep 20163:15 pmRNSMonthly Update
2nd Sep 20163:00 pmRNSNet Asset Value(s)
30th Aug 20163:34 pmRNSHolding(s) in Company
24th Aug 20169:02 amRNSAppointment of Principal at VPC Advisors, LLC
17th Aug 20167:00 amRNSDividend Declaration
3rd Aug 20163:35 pmRNSMonthly Update
3rd Aug 20163:35 pmRNSQuarterly Letter
3rd Aug 20163:00 pmRNSNet Asset Value(s)
5th Jul 20163:30 pmRNSMonthly Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.